Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302-Reference-Cited by-同舟云学术

Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302

Published:2017-04 Issue:4 Volume:71 Page:656-664
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

de Bono Johann S.,Smith Matthew R.,Saad Fred,Rathkopf Dana E.,Mulders Peter F.A.,Small Eric J.,Shore Neal D.,Fizazi Karim,De Porre Peter,Kheoh Thian,Li Jinhui,Todd Mary B.,Ryan Charles J.,Flaig Thomas W.

Publisher

Elsevier BV

Subject

Urology

Reference40 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

2. Cancer statistics, 2014;Siegel;Cancer J Clin,2014

3. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

5. Prostate cancer: ESMO Consensus Conference Guidelines 2012;Horwich;Ann Oncol,2013

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08

2. Second-line treatment options in metastatic castration-resistant prostate cancer after progression on first-line androgen-receptor targeting therapies: A systematic review and Bayesian network analysis;Critical Reviews in Oncology/Hematology;2024-04

3. The Prognostic Nutritional Index (PNI): A New Biomarker for Determining Prognosis in Metastatic Castration-Sensitive Prostate Carcinoma;Journal of Clinical Medicine;2023-08-22

5. Impact of DNA damage repair alterations on prostate cancer progression and metastasis;Frontiers in Oncology;2023-06-26